Trial Profile

A Randomized, Open-label, Four-Way Crossover Study to Compare the Bioavailability of a Single Dose of Epanova or Lovaza After a Low-Fat and High-Fat Meal.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 22 Jul 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Omega-3 carboxylic acids (Primary) ; Omega-3-acid ethyl esters
Indications Crohn's disease; Hypertriglyceridaemia
Focus Pharmacokinetics
Acronyms ECLIPSE

Most Recent Events

10 Jan 2012 Long-term (2-week) bioavailability data were presented at the J.P. Morgan Healthcare Conference.
16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
17 May 2011 Trial phase changed from I/II to II as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com